ONYX PHARMACEUTICALS INC Interest Expense
ONYX PHARMACEUTICALS INC reported Interest Expense of $5.71 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2013-08-09
- ONYX PHARMACEUTICALS INC interest expense for the quarter ending 2013-06-30 was $5.71M, a 6.29% increase year-over-year.
- ONYX PHARMACEUTICALS INC interest expense for the quarter ending 2013-03-31 was $5.63M, a 6.23% increase year-over-year.
- ONYX PHARMACEUTICALS INC interest expense for the quarter ending 2012-12-31 was $5.66M, a 11.64% increase year-over-year.
- ONYX PHARMACEUTICALS INC interest expense for the quarter ending 2012-09-30 was $5.46M, a 6.73% increase year-over-year.
- ONYX PHARMACEUTICALS INC interest expense for fiscal 2012 was $21.79M, a 7.72% increase from fiscal 2011.
- ONYX PHARMACEUTICALS INC interest expense for fiscal 2011 was $20.22M, a 4.25% increase from fiscal 2010.
- ONYX PHARMACEUTICALS INC interest expense for fiscal 2010 was $19.40M, a 182.88% increase from fiscal 2009.
- ONYX PHARMACEUTICALS INC interest expense for fiscal 2009 was $6.86M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2013-06-30 | $5.71M 10-Q · filed 2013-08-09 | $11.34M 10-Q · filed 2013-08-09 | $17.00M derived: sum of 3 quarters · filed 2013-08-09 | $22.45M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $5.63M 10-Q · filed 2013-05-08 | $11.29M derived: sum of 2 quarters · filed 2013-05-08 | $16.74M derived: sum of 3 quarters · filed 2013-05-08 | $22.11M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $5.66M 10-K · filed 2013-02-28 | $11.12M derived: sum of 2 quarters · filed 2013-02-28 | $16.49M derived: sum of 3 quarters · filed 2013-08-09 | $21.79M 10-K · filed 2013-02-28 |
| 2012-09-30 | $5.46M 10-K · filed 2013-02-28 | $10.83M derived: sum of 2 quarters · filed 2013-08-09 | $16.13M 10-Q · filed 2012-11-02 | $21.20M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $5.37M 10-Q · filed 2013-08-09 | $10.67M 10-Q · filed 2013-08-09 | $15.74M derived: sum of 3 quarters · filed 2013-08-09 | $20.85M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $5.30M 10-Q · filed 2013-05-08 | $10.37M derived: sum of 2 quarters · filed 2013-05-08 | $15.48M derived: sum of 3 quarters · filed 2013-05-08 | $20.52M derived: sum of 4 quarters · filed 2013-05-08 |
| 2011-12-31 | $5.07M 10-K · filed 2013-02-28 | $10.18M derived: sum of 2 quarters · filed 2013-02-28 | $15.22M derived: sum of 3 quarters · filed 2013-02-28 | $20.22M 10-K · filed 2013-02-28 |
| 2011-09-30 | $5.11M 10-K · filed 2013-02-28 | $10.15M derived: sum of 2 quarters · filed 2013-02-28 | $15.15M 10-Q · filed 2012-11-02 | $20.09M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $5.04M 10-K · filed 2013-02-28 | $10.04M 10-Q · filed 2012-08-06 | $14.98M derived: sum of 3 quarters · filed 2013-02-28 | $19.92M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $5.00M 10-K · filed 2013-02-28 | $9.94M derived: sum of 2 quarters · filed 2013-02-28 | $14.88M derived: sum of 3 quarters · filed 2013-02-28 | $19.68M derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | $4.93M 10-K · filed 2012-02-27 | $9.88M derived: sum of 2 quarters · filed 2012-02-27 | $14.68M derived: sum of 3 quarters · filed 2012-02-27 | $19.40M 10-K · filed 2013-02-28 |
| 2010-09-30 | $4.94M 10-K · filed 2012-02-27 | $9.74M derived: sum of 2 quarters · filed 2012-02-27 | $14.47M 10-Q · filed 2011-11-03 | $19.07M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | $4.80M 10-K · filed 2012-02-27 | $9.53M 10-Q · filed 2011-08-09 | $14.13M derived: sum of 3 quarters · filed 2012-02-27 | $16.38M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | $4.72M 10-K · filed 2012-02-27 | $9.33M derived: sum of 2 quarters · filed 2012-02-27 | $11.58M derived: sum of 3 quarters · filed 2012-02-27 | |
| 2009-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $6.86M derived: sum of 2 quarters · filed 2012-02-27 | $6.86M 10-K · filed 2012-02-27 | |
| 2009-09-30 | $2.25M 10-Q · filed 2010-11-03 | $2.25M 10-Q · filed 2010-11-03 | ||
| 2008-12-31 | $0.00 10-K · filed 2011-02-23 |